Trials / Sponsors / SillaJen, Inc.
SillaJen, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer, Gastric Cancer | Phase 1 | 2022-12-14 |
| Active Not Recruiting | A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma Renal Cell Carcinoma | Phase 1 / Phase 2 | 2018-06-07 |
| Completed | Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone Hepatocellular Carcinoma (HCC) | Phase 3 | 2015-10-01 |